
DFTX Technical Analysis Summary (NASDAQ)
Analyze DFTX on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerDFTX Technical Analysis Summary (NASDAQ)
Definium Therapeutics, Inc. (NASDAQ: DFTX) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.
Technical conditions suggest Definium Therapeutics, Inc. on the NASDAQ is awaiting a decisive move. Technical conditions suggest Definium Therapeutics, Inc. is consolidating, awaiting a decisive move.
RSI (14): 47.40
Stochastic %K: 21.64
Williams %R: -62.16
Rate of Change (ROC): -6.98
Takeaway:Definium Therapeutics, Inc. shows weakening momentum, with sellers gaining the edge.
MACD: -1.22
ADX: 24.13
ATR (14): 2.33
CCI (14): 31.40
Takeaway:Definium Therapeutics, Inc. shows a firm trend supported by momentum, though one signal suggests caution.
Takeaway:Definium Therapeutics, Inc. trades closer to support, showing weaker momentum within bands.
Takeaway:Definium Therapeutics, Inc. trades below the trend line, showing weaker momentum inside the channel.
Overall Takeaway:DFTX shows neutral money flow, with no clear directional pressure.
Bullish Signals
ADX above 20 → strong underlying trend.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Definium Therapeutics, Inc. shows a Bearish signal — selling pressure is building, with trend indicators favoring downside.